Latest Capricor Therapeutics News & Updates

See the latest news and media coverage for Capricor. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Capricor Therapeutics (Capricor)

Biotechnology company developing cell and exosome-based therapeutics

capricor.com
Headquarters
San Diego, United States
Founded year
2005
Company type
Public company
Number of employees
200–280
Industry
Pharmaceuticals

Last updated

Latest news about Capricor Therapeutics (Capricor)

In short: Capricor’s FDA review of Deramiocel was extended to November while 24-month HOPE-3 data showed slower upper-limb decline.

Company announcements

Capricor

Capricor Therapeutics presents positive HOPE-3 data

Deramiocel slowed upper limb decline by 76% in DMD patients during the open-label extension study. Data were submitted as part of the Biologics License Application ahead of the November 22 PDUFA date.

Capricor

Capricor reports Q2 2026 financial results and Deramiocel update

Cash at $238M, net loss widened to $40.7M, FDA advisory committee voted against, but HOPE-3 published in The Lancet.

Unlock all announcements with a

Media coverage

Reuters

Capricor s Duchenne drug gets three-month FDA extension after new data submission

Capricor Therapeutics said on Monday the U.S. Food and ​Drug Administration had extended the review ...

Unlock all articles with a

Never miss news about Capricor

Track Capricor and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.